Advanced search
Publication Cover
Journal of Pain & Palliative Care Pharmacotherapy Volume 25, 2011 - Issue 1
Submit an article Journal homepage
200
Views
5
CrossRef citations to date
0
Altmetric
PAIN MANAGEMENT IN PRIMARY CARE

Using the Medical Food Flavocoxid in Managing Osteoarthritis

Daniel Gottlieb Daniel Gottlieb, MD, is a senior resident in the University of Florida Family Medicine Residency Program; Louis Kuritzky, MD, is a Clinical Assistant Professor of Community Health and Family Medicine and is with the Family Medicine Residency Program, University of Florida, Gainesville, Florida, USA.
&
Louis Kuritzky Daniel Gottlieb, MD, is a senior resident in the University of Florida Family Medicine Residency Program; Louis Kuritzky, MD, is a Clinical Assistant Professor of Community Health and Family Medicine and is with the Family Medicine Residency Program, University of Florida, Gainesville, Florida, USA.
Pages 49-54 | Published online: 24 Mar 2011

REFERENCES

  • Silverstein FE, Faich G, Goldstein JL, Simon LS, Pinkus T, Whelton A, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. JAMA. 2000;284:1247–1255.
  • Hrachover JB, Mora M. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. JAMA. 2001;286:2399–2400.
  • Wright JM, Perry TL, Bassett KL, Chambers GK. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. JAMA. 2001;286:2398–2399.
  • Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, National Arthritis Data: estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II, Arthritis Rheum. 2008;58:26–35.
  • Levy RM, Khokhlov A, Kopenkin S, Bart B, Ermolova T, Kantemirova R, Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee. Adv Ther. 2010;27:1–12.
  • Walton MS, Schumack GT, McLain DA. Cost analysis of flavocoxid compared to naproxen for management of mild to moderate OA. Curr Med Res Opin. 2010;26:2253–2261.
  • Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med. 1998;105(1B): 31S–38S.
  • Altavilla D, Squadrito F, Bitto A, Polito F, Burnett BP, Di Stefano V, Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxyenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages. Br J Pharmacol. 2009;157:1410–1418.
  • Khanapure SP, Garvey DS, Janero DR, Letts LG. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem. 2007;7:311–340.
  • Levy RM, Saikovsky R, Shmidt E, Khokhlov A, Burnett BP. Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans; a short-term randomized, double-blind pilot study. Nutr Res. 2009;29:298–304.
  • Antman EM, DeMets D, Loscalzo J. Cyclooxygenase inhibition and cardiovascular risk. Circulation. 2005;112:759–770.
  • Public Health Advisory—FDA Announces Important Changes and Additional Warnings for COX-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDS). April 7, 2005. Available at: http://www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsand- Providers/ucm150314.htm. Accessed December 12, 2010.
  • Hudson N, Balsitis M, Everitt S, Hawkey CJ. Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut. 1993;34:742–747.
  • Mehrabian M, Allayee H, Wong J, Shi W, Wang XP, Shaposhnik Z Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res. 2002;91:120–126.
  • U.S. Food and Drug Administration. Available at: http://www. fda.gov/Food/GuidanceComplianceRegulatoryInformation/ GuidanceDocuments/MedicalFoods/ucm054048.htm. Accessed December 12, 2010.
  • Morgan SL, Baggott JE, Moreland L, Desmond R, Kendrach A. The safety of flavocoxid, a medical food, in the dietary management of knee osteoarthritis. J Med Food. 2009;12:1143–1148.
  • Limbrel Package Insert, Primus Pharmaceuticals. Available at: http://www.limbrel.com/downloads/limbrel_pi.pdf. Accessed December 12, 2010.
  • Yamada H, Takuma N, Daimon T, Hara Y. Gargling with tea catechin extracts for the prevention of influenza infection in elderly nursing home residents; a prospective clinical study. J Altern Complement Med. 2006;12:669–672.
  • Burnett BP, Jia Q, Zhao Y, Levy RM. A medicinal extract of Scutelaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation. J Med Food. 2007;10:442–451.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.